iRobot Reports Q4 Adjusted Loss, Misses Revenue Estimates

Zacks
03-13

iRobot Corporation IRBT reported fourth-quarter 2024 adjusted loss of $2.06 per share, wider than the Zacks Consensus Estimate of a loss of $1.45 per share. The reported figure compares favorably with the year-ago quarter’s net loss of $1.82 per share.

Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.

IRBT’s Revenue Details

iRobot generated revenues of $172 million, which missed the Zacks Consensus Estimate of $191 million. On a year-over-year basis, revenues declined 44.1% due to decrease in sales of two-in-one products.

Sales derived from premium and mid-tier robots accounted for 83% of IRBT’s total robot revenues, higher than 82% in the year-ago quarter.

Total product units of 701 thousand were shipped, reflecting a year-over-year decrease of 38.5%, while average selling prices declined 1.4%.

For solo and other products, revenues of $72 million reflected a decline of 61.1% year over year. Units shipped were 279 thousand, down 60.9% year over year.

Revenues from two-in-one products decreased 18.7% year over year to $100 million. Units shipped were 422 thousand, down from 425 thousand in the year-ago quarter.

On a regional basis, iRobot sourced 43.2% of revenues from domestic operations, while the rest came from the international arena. Domestic revenues totaled $74.3 million, reflecting a 46.9% decrease on a year-over-year basis. International revenues decreased 41.7% year over year to $97.7 million.









iRobot Corporation Price, Consensus and EPS Surprise

iRobot Corporation price-consensus-eps-surprise-chart | iRobot Corporation Quote

IRBT’s Margin Profile

The cost of revenues decreased 37.5% year over year to $155.6 million. Gross profit was $16.4 million, down 71.8% year over year, while the gross margin decreased 940 basis points to 9.5%.

Research and development expenses were $16.5 million, down 39% year over year. Selling and marketing expenses declined 33.2% on a year-over-year basis to $39.9 million.

IRBT recorded an operating loss of $61 million compared with $52.2 million loss in the year-ago quarter. The adjusted operating margin was (26%) compared with (14.7%) in the year-ago quarter.



IRBT’s Balance Sheet and Cash Flow

While exiting the fourth quarter 2024, iRobot had cash and cash equivalents of $134.3 million compared with $185.1 million at the end of 2023. Total long-term liabilities were $236.6 million compared with $250.1 million at 2023-end.

In 2024, the company used net cash of $33.2 million from operating activities compared with $114.8 million in the prior-year period.

Stocks to Consider

IRBT currently carries a Zacks Rank #3 (Hold).

Some better-ranked companies from the same space are discussed below.

RBC Bearings Incorporated RBC currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

RBC delivered a trailing four-quarter average earnings surprise of 4.9%. In the past 60 days, the Zacks Consensus Estimate for RBC’s fiscal 2025 earnings has increased 1.2%.

Applied Industrial Technologies, Inc. AIT presently carries a Zacks Rank #2 (Buy). It has a trailing four-quarter average earnings surprise of 5.3%. The Zacks Consensus Estimate for AIT’s fiscal 2025 (ending June 2025) earnings has improved 1.4% in the past 60 days.

The Middleby Corporation MIDD presently carries a Zacks Rank of 2. MIDD delivered a trailing four-quarter average earnings surprise of 1.9%.
In the past 60 days, the consensus estimate for MIDD’s 2025 earnings has inched up 0.8%.










Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

RBC Bearings Incorporated (RBC) : Free Stock Analysis Report

Applied Industrial Technologies, Inc. (AIT) : Free Stock Analysis Report

The Middleby Corporation (MIDD) : Free Stock Analysis Report

iRobot Corporation (IRBT) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10